Fanapt
Generic Name:
Brand Names:
Fanapt
Fanapt Description:
Fanapt is an atypical antipsychotic medication prescribed to treat patients with schizophrenia.
Fanapt Side Effects:
The most common side effects of Fanapt are:
- Restlessness
- Involuntary movements or facial tics
- Tremors
- Muscle stiffness
- Nausea
- Weight gain
For more information, see our Fanapt side effects page.
Fanapt Uses:
Fanapt is a medication prescribed to treat patients with schizophrenia who experience symptoms of social withdrawal, apathy, emotional unresponsiveness, hallucinations, delusions, agitation, and disorganized thinking.
Fanapt Interactions:
Other medications may interact with Fanapt or increase the risk of side effects. Discuss any medications, supplements, or vitamins with your doctor before taking Fanapt.
The following medications may interact with Fanapt:
- Antifungals
- Antidepressants
- Bupropion (Wellbutrin)
- Antibiotics
- Antipsychotics
- HIV protease inhibitors
- Antiarrhythmics
- Anxiety medications
- High blood pressure medications
- Seizure medications
- Methadone
- Moxifloxacin
- Pentamidine
- Procainamide
- Quinidine
- Sotalol
- Sedatives
- Sleeping pills
- Tranquilizers
Patients with a history or current diagnosis of any of the following conditions should consult their doctor before beginning treatment with Fanapt:
- Alzheimer’s disease
- Dehydration
- Heart problems
- Hypotension
- Hypovolemia
- Stroke
- Difficulty swallowing
- Cancer
- Blood or bone marrow problems
- Diabetes
- Hyperglycemia
- High blood prolactin
- Neuroleptic malignant syndrome
- Seizures
- Stomach/bowel problems
- Prolonged QT interval
- Kidney disease
- Liver disease
- Slow heartbeat
- Blood vessel disease
This is not a complete list of possible Fanapt interactions. Consult your doctor about any possible interactions with this medicine.
Fanapt Dosage Information:
Typical Dosage Recommendations
Patients should take Fanapt exactly as prescribed by a doctor, as dosage recommendations differ for the treatment of various conditions.
Fanapt is distributed as a 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg tablet. Patients may begin at an initial dose of 1 mg two times a day. Doses may be increased as needed, but should not exceed more than 12 mg two times a day.
Missing a Dose of Fanapt
If you miss a dose of Fanapt, take it as soon as you remember. If you are close to your next dose, skip the missed dose and resume your normal dosage schedule. Do not take a double dose of this medicine.
Fanapt Overdose
Call your doctor immediately if you believe you are experiencing any of the following overdose symptoms:
- Drowsiness
- Slowed movement
- Palpitations
Fanapt FDA Approval:
May 6, 2009
Fanapt Recall/Black Box Warning Information:
Fanapt carries a Black Box warning for elderly patients with dementia. These patients should not take Fanapt because of an increased risk of fatality. Older patients with dementia who take Fanapt may have a greater chance of having a stroke during treatment.
There are no recalls associated with Fanapt.
Other Warnings
Tardive Dyskinesia (TD), a condition that causes uncontrollable movement of the face, tongue, and other body parts, is a serious and sometimes permanent side effect of Fanapt. Chances of developing TD increase as treatment with Fanapt is extended over time.
Fanapt may raise your blood sugar levels. Patients, who have diabetes or risk factors for developing diabetes, should consult their doctor before beginning treatment with Fanapt.
Fanapt may raise levels of prolactin in the blood, causing a condition called hyperprolactinemia. This may stop menstrual periods and hinder milk production in women, cause men to develop breasts or prevent men from developing an erection.
Neuroleptic Malignant Syndrome (NMS) is a potentially fatal side effect of Fanapt. Patients should call their doctor immediately if they have symptoms of high fever, stiff muscles, shaking, confusion, sweating, changes in pulse, and heart rate. These are all potential symptoms for NMS.
-
May 9, 2011, 1:27 pm
-
May 6, 2011, 1:37 pm
-
May 5, 2011, 12:55 pm
-
May 4, 2011, 1:29 pm
